S&P 500   3,976.80 (+0.15%)
DOW   32,431.21 (+0.60%)
QQQ   309.20 (-0.54%)
AAPL   158.36 (-1.18%)
MSFT   276.88 (-1.32%)
META   202.93 (-1.50%)
GOOGL   102.63 (-2.67%)
AMZN   98.24 (+0.11%)
TSLA   192.37 (+1.03%)
NVDA   265.12 (-1.00%)
NIO   8.98 (-0.99%)
BABA   86.11 (-0.91%)
AMD   96.78 (-1.19%)
T   18.89 (+1.50%)
F   11.55 (+0.35%)
MU   60.04 (-1.83%)
CGC   1.89 (-0.65%)
GE   93.21 (+2.01%)
DIS   95.83 (+1.86%)
AMC   4.53 (+1.34%)
PFE   40.19 (-0.50%)
PYPL   73.45 (-0.58%)
NFLX   328.34 (-0.02%)
S&P 500   3,976.80 (+0.15%)
DOW   32,431.21 (+0.60%)
QQQ   309.20 (-0.54%)
AAPL   158.36 (-1.18%)
MSFT   276.88 (-1.32%)
META   202.93 (-1.50%)
GOOGL   102.63 (-2.67%)
AMZN   98.24 (+0.11%)
TSLA   192.37 (+1.03%)
NVDA   265.12 (-1.00%)
NIO   8.98 (-0.99%)
BABA   86.11 (-0.91%)
AMD   96.78 (-1.19%)
T   18.89 (+1.50%)
F   11.55 (+0.35%)
MU   60.04 (-1.83%)
CGC   1.89 (-0.65%)
GE   93.21 (+2.01%)
DIS   95.83 (+1.86%)
AMC   4.53 (+1.34%)
PFE   40.19 (-0.50%)
PYPL   73.45 (-0.58%)
NFLX   328.34 (-0.02%)
S&P 500   3,976.80 (+0.15%)
DOW   32,431.21 (+0.60%)
QQQ   309.20 (-0.54%)
AAPL   158.36 (-1.18%)
MSFT   276.88 (-1.32%)
META   202.93 (-1.50%)
GOOGL   102.63 (-2.67%)
AMZN   98.24 (+0.11%)
TSLA   192.37 (+1.03%)
NVDA   265.12 (-1.00%)
NIO   8.98 (-0.99%)
BABA   86.11 (-0.91%)
AMD   96.78 (-1.19%)
T   18.89 (+1.50%)
F   11.55 (+0.35%)
MU   60.04 (-1.83%)
CGC   1.89 (-0.65%)
GE   93.21 (+2.01%)
DIS   95.83 (+1.86%)
AMC   4.53 (+1.34%)
PFE   40.19 (-0.50%)
PYPL   73.45 (-0.58%)
NFLX   328.34 (-0.02%)
S&P 500   3,976.80 (+0.15%)
DOW   32,431.21 (+0.60%)
QQQ   309.20 (-0.54%)
AAPL   158.36 (-1.18%)
MSFT   276.88 (-1.32%)
META   202.93 (-1.50%)
GOOGL   102.63 (-2.67%)
AMZN   98.24 (+0.11%)
TSLA   192.37 (+1.03%)
NVDA   265.12 (-1.00%)
NIO   8.98 (-0.99%)
BABA   86.11 (-0.91%)
AMD   96.78 (-1.19%)
T   18.89 (+1.50%)
F   11.55 (+0.35%)
MU   60.04 (-1.83%)
CGC   1.89 (-0.65%)
GE   93.21 (+2.01%)
DIS   95.83 (+1.86%)
AMC   4.53 (+1.34%)
PFE   40.19 (-0.50%)
PYPL   73.45 (-0.58%)
NFLX   328.34 (-0.02%)
OTCMKTS:KHTRF

Knight Therapeutics - KHTRF Competitors

$3.47
-0.11 (-2.98%)
(As of 03/24/2023 08:52 PM ET)
Add
Compare
Today's Range
$3.47
▼
$3.47
50-Day Range
$3.47
▼
$3.96
52-Week Range
$3.47
▼
$4.77
Volume
100 shs
Average Volume
2,388 shs
Market Capitalization
N/A
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
$6.08

KHTRF vs. TGIFF, FFNTF, ABSCF, ABAHF, ACRHF, ACRGF, ACRDF, AGFAF, ALEAF, and ACGWF

Should you be buying Knight Therapeutics stock or one of its competitors? The main competitors of Knight Therapeutics include 1933 Industries (TGIFF), 4Front Ventures (FFNTF), AB Science (ABSCF), Abacus Health Products (ABAHF), Acreage (ACRHF), Acreage (ACRGF), Acreage (ACRDF), Agra Ventures (AGFAF), Aleafia Health (ALEAF), and Alliance Growers (ACGWF). These companies are all part of the "drug manufacturers - specialty & generic" industry.

Knight Therapeutics vs.

1933 Industries (OTCMKTS:TGIFF) and Knight Therapeutics (OTCMKTS:KHTRF) are both medical companies, but which is the superior stock? We will compare the two companies based on the strength of their profitability, risk, media sentiment, valuation, earnings, institutional ownership, analyst recommendations, dividends and community ranking.

Knight Therapeutics has a consensus price target of $6.08, indicating a potential upside of 75.07%. Given Knight Therapeutics' higher probable upside, analysts plainly believe Knight Therapeutics is more favorable than 1933 Industries.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
1933 Industries
0 Sell rating(s)
0 Hold rating(s)
0 Buy rating(s)
0 Strong Buy rating(s)
N/A
Knight Therapeutics
0 Sell rating(s)
0 Hold rating(s)
0 Buy rating(s)
0 Strong Buy rating(s)
N/A

Knight Therapeutics received 101 more outperform votes than 1933 Industries when rated by MarketBeat users.

CompanyUnderperformOutperform
1933 IndustriesN/AN/A
Knight TherapeuticsOutperform Votes
101
67.79%
Underperform Votes
48
32.21%

Company Net Margins Return on Equity Return on Assets
1933 Industries N/A N/A N/A
Knight Therapeutics N/A N/A N/A

24.9% of Knight Therapeutics shares are held by institutional investors. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a stock is poised for long-term growth.

In the previous week, Knight Therapeutics had 3 more articles in the media than 1933 Industries. MarketBeat recorded 4 mentions for Knight Therapeutics and 1 mentions for 1933 Industries. 1933 Industries' average media sentiment score of 1.47 beat Knight Therapeutics' score of 0.20 indicating that 1933 Industries is being referred to more favorably in the media.

Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment
1933 Industries
1 Very Positive mention(s)
0 Positive mention(s)
0 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Positive
Knight Therapeutics
0 Very Positive mention(s)
0 Positive mention(s)
4 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Neutral

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
1933 IndustriesN/AN/AN/AN/AN/A
Knight TherapeuticsN/AN/AN/AN/AN/A

Summary

Knight Therapeutics beats 1933 Industries on 4 of the 5 factors compared between the two stocks.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding KHTRF and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Skip Chart

Media Sentiment Over Time

This chart shows the average media sentiment of OTCMKTS and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

KHTRF vs. The Competition

Export to Excel
MetricKnight TherapeuticsDrug Manufacturers IndustryMedical SectorOTCMKTS Exchange
Market CapN/A$1.45B$4.27B$7.05B
Dividend YieldN/A1.57%5.97%4.98%
P/E RatioN/A59.0286.938.07
Price / SalesN/A11,068.553,212.33125.16
Price / CashN/A9.7526.9919.70
Price / BookN/A3.124.246.83
Net IncomeN/A-$47.31M$113.62M$719.50M
7 Day PerformanceN/A2,211.65%113.17%49.40%
1 Month Performance-7.54%2,302.31%106.16%47.36%
1 Year PerformanceN/A2,582.79%107.67%41.79%

Knight Therapeutics Competitors List

Export to Excel
CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
TGIFF
1933 Industries
0 of 5 stars		$0.01
flat		N/A-70.5%$0.00N/A0.00147,000Upcoming Earnings
Gap Down
FFNTF
4Front Ventures
0 of 5 stars		$0.23
flat		$1.00
+340.5%		-73.8%$0.00N/A0.00464Upcoming Earnings
Short Interest ↓
News Coverage
High Trading Volume
ABSCF
AB Science
0 of 5 stars		$9.00
flat		N/AN/A$0.00N/A0.0096
ABAHF
Abacus Health Products
0 of 5 stars		$4.84
-5.1%		N/A+0.0%$0.00N/A0.0029Gap Down
ACRHF
Acreage
0 of 5 stars		$0.54
+3.8%		N/A-72.4%$0.00N/A0.001,090Short Interest ↑
Gap Down
ACRGF
Acreage
0 of 5 stars		$2.77
flat		N/AN/A$0.00N/A0.00N/APositive News
ACRDF
Acreage
0 of 5 stars		$0.74
-8.7%		$1.44
+95.7%		-55.0%$0.00N/A0.001,090Short Interest ↑
AGFAF
Agra Ventures
0 of 5 stars		$0.01
flat		N/A-97.7%$0.00N/A0.00N/ANews Coverage
ALEAF
Aleafia Health
0 of 5 stars		$0.04
flat		N/A-56.3%$0.00N/A0.00173Short Interest ↑
News Coverage
ACGWF
Alliance Growers
0 of 5 stars		N/AN/AN/AC$0.00N/A0.00N/AGap Up
This page (OTCMKTS:KHTRF) was last updated on 3/27/2023 by MarketBeat.com Staff